Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Daniel Eriksson's publication output changed over time?
ScholarIQpublication output · 2016–2019
Output grew200% over the shown period — from 2 works in 2016 to 6 in 2019.
2
1
1
6
2016201720182019
What are the most-cited papers on Daniel Eriksson?
ScholarIQmost cited works
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis
Craig I Coleman, Reinhold Kreutz, Nitesh Sood, Thomas J. Bunz, Daniel Eriksson, Anna‐Katharina Meinecke, William L. Baker
The American Journal of Medicine. 2019123 Citations
Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis
Nicole Hannemann, Shan Cao, Daniel Eriksson, Anne Schnelzer, Jutta Jordan, Martin Eberhardt, Ulrike Schleicher, Jürgen Rech, Andreas Ramming, Steffen Uebe, Arif B. Ekici, Juan D. Cañete, Xiaoxiang Chen, Tobias Bäuerle, Julio Vera, Christian Bogdan, Georg Schett, Aline Bözec
S114430552. 2019118 CitationsOPEN ACCESS
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia
Daniel Eriksson, David Goldsmith, S Teitsson, James Jackson, Floortje van Nooten
BMC Nephrology. 2016102 CitationsOPEN ACCESS
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes
Adrían V. Hernández, G. Bradley, Mohammad Khan, Andrew J Fratoni, Anna Gasparini, Yuani M. Roman, Thomas J. Bunz, Daniel Eriksson, Anna‐Katharina Meinecke, Craig I Coleman
European Heart Journal - Quality of Care and Clinical Outcomes. 201967 Citations
Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis
Craig I Coleman, Reinhold Kreutz, Nitesh Sood, Thomas J. Bunz, Anna‐Katharina Meinecke, Daniel Eriksson, William L. Baker
S8942861. 201959 CitationsOPEN ACCESS
Related on ScholarIQ
Uppsala University
Institution
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis
Paper
Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis
Paper
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia
Paper
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes
Paper
Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis
Paper